References
- K. M. Burbach, A. Poland and C. A. Bradfield, "Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor", Proceedings of the National Academy of Sciences, USA, Vol. 89, No. 17, pp. 8185-8189 1992. https://doi.org/10.1073/pnas.89.17.8185
- A. B. Okey, D. S. Riddick and P. A. Harper, "Molecular biology of the aromatic hydrocarbon (dioxin) receptor", Trends in Pharmacological Sciences, Vol. 15, No. 7, pp. 226-232 1994. https://doi.org/10.1016/0165-6147(94)90316-6
- C. Ma, J. L. Marlowe and A. Puga, "The aryl hydrocarbon receptor at the crossroads of multiple signaling pathways", EXS Vol. 99, pp. 231-257, 2009.
- E. J. Choi, D. G. Toscano, J. A. Ryan, N. Riedel and W. A. Toscano, Jr., "Dioxin induces transforming growth factor-alpha in human keratinocytes", The Journal of Biological Chemistry, Vol. 266, No. 15, pp. 9591-9597, 1991.
- A. Levine-Fridman, L. Chen and C. J. Elferink, "Cytochrome P4501A1 promotes G1 phase cell cycle progression by controlling aryl hydrocarbon receptor activity", Molecular Pharmacology, Vol. 65, No. 2, pp. 461-469, 2004. https://doi.org/10.1124/mol.65.2.461
- F. Yang and D. Bleich, "Transcriptional regulation of cyclooxygenase-2 gene in pancreatic beta-cells", Journal of Biological Chemistry, Vol. 279, No. 34, pp. 35403-35411, 2004. https://doi.org/10.1074/jbc.M404055200
- J. Guo, M. Sartor, S. Karyala, M. Medvedovic, S. Kann, A. Puga, P. Ryan and C. R. Tomlinson, "Expression of genes in the TGF-beta signaling pathway is significantly deregulated in smooth muscle cells from aorta of aryl hydrocarbon receptor knockout mice", Toxicology and Applied Pharmacology, Vol. 194, No. 1, pp. 79-89, 2004. https://doi.org/10.1016/j.taap.2003.09.002
- B. D. Abbott, G. H. Perdew and L. S. Birnbaum, "Ah receptor in embryonic mouse palate and effects of TCDD on receptor expression", Toxicology and Applied Pharmacology, Vol. 126, No. 1, pp. 16-25, 1989. https://doi.org/10.1006/taap.1994.1085
- E. A. Thackaberry, E. J. Bedrick, M. B. Goens, L. Danielson, A. K. Lund, D. Gabaldon, S. M. Smith and M. K. Walker, "Insulin regulation in AhR-null mice: embryonic cardiac enlargement, neonatal macrosomia, and altered insulin regulation and response in pregnant and aging AhR-null females", Toxicological Sciences, Vol. 76, No. 2, pp. 407-417, 2003. https://doi.org/10.1093/toxsci/kfg229
- P. Fernandez-Salguero, T. Pineau, D. M. Hilbert, T. McPhail, S. S. Lee, S. Kimura, D. W. Nebert, S. Rudikoff, J. M. Ward and F. J. Gonzalez, "Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor", Science, Vol. 268, No. 5211, pp. 722-726, 1995. https://doi.org/10.1126/science.7732381
- H. Lee, "Development of Novel AHR Antagonists", Doctoral Dissertation, University of Kentucky, 2010.
- Y. F. Lu, M. Santostefano, B. D. Cunningham, M. D. Threadgill and S. Safe, "Substituted flavones as aryl hydrocarbon receptor agonists and antagonists", Biochemical Pharmacology, Vol. 51, No. 8, pp. 1077-1087, 1996. https://doi.org/10.1016/0006-2952(96)00063-9
- J. E. Lee and S. Safe, "3',4'-dimethoxyflavone as an aryl hydrocarbon receptor antagonist in human breast cancer cells", Toxicological Sciences, Vol. 58, No. 2, pp. 235-242, 2000. https://doi.org/10.1093/toxsci/58.2.235
- J. J. Reiners, Jr., R. Clift and P. Mathieu, "Suppression of cell cycle progression by flavonoids: dependence on the aryl hydrocarbon receptor", Carcinogenesis, Vol. 20, No. 8, pp. 1561-1566, 1999. https://doi.org/10.1093/carcin/20.8.1561
- B. D. Cunningham, M. D. Threadgill, P. W. Groundwater, I. L. Dale and J. A. Hickman, "Synthesis and biological evaluation of a series of flavones designed as inhibitors of protein tyrosine kinases", Anticancer Drug Design, Vol. 7, No. 5, pp. 365-384, 1992.
- E. Y. Choi, H. Lee, R. W. Dingle, K. B. Kim and H. I. Swanson, "AHR-based Therapeutic Agents", Molecular and Cellular Pharmacology, Vol. 4, No. 2, pp. 53-60, 2012